Print
Share
RSS
Donate
News
AZCERT's Scientific Review Committee has reviewed available evidence for Remdesivir, an antiviral drug used to treat COVID-19, and found that its use is associated with the development of QTc prolongation. This analysis failed to find compelling…
New icons to convey different categories of risk... To aid in the review and use of these lists, the CredibleMeds website employs specific icons for the risk categories and the drugs on the List of Drugs to Avoid by cLQTS patients. To facilitate…
The QTdrugs List includes three distinct risk categories for Torsades de Pointes (TdP) and QT prolongation but not all drugs in the List should be considered “QT prolonging”. Because of the inherent complexity of drug-induced QT prolongation and the…
Deutetrabenazine (used to treat tardive dyskinesia) and Dexmedetomidine (a sedative) were removed from the Possible Risk of TdP category and are no longer on the QTdrugs list. Our analysis of new evidence did not support their continued placement on…
Informing you of the the following changes made to the QTdrugs List February 25, 2022
Text for citing the use of the QTdrugs List or the CredibleMeds.org website:
Woosley RL, Heise CW, Gallo T, Woosley RD, Lambson J. and Romero KA, www.CredibleMeds.org, QTdrugs List, [Accession Date], AZCERT, 1457 E. Desert Garden Dr., Tucson, AZ 85718
Copyright: The CredibleMeds® website is intended for personal and professional use only. Its content is protected by U.S. Copyright. Unauthorized use for commercial purposes is prohibited.